Patients implanted with brain chips from Elon Musk’s Neuralink have begun to control robots’ arms with their thoughts, the company said.
“Participants in our clinical trials have extended digital computer control to physical devices such as assistive robotic arms,” Neuralink posted Dec. 2 on X. “Over time, we plan to expand the range of devices controllable via Neuralink.”
The startup raised $650 million in venture capital funding in June, following the successful implantation of a brain-computer interface in a patient at University of Miami Health System in April.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
